SEC Form 4 · accession 0001209191-17-049882
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephana Eilene Patton
Officer — General Counsel
Period of report
Aug 21, 2017
Accepted (ET)
Aug 22, 2017 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value | Aug 21, 2017 | P | 7,500 | $2.5835 | A | 7,500 | D |
Table II — derivative securities
No Table II lines on this filing.